Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (PACTR202609620071588) titled 'Combined Hydroxyurea-Losartan Therapy for Early Sickle Cell Nephropathy in Children: A Multicenter Randomized Trial in Sub-Saharan Africa' on Sept. 7.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Permuted block randomization,Allocation was determined by the holder of the sequence who is situated off site
Primary Sponsor: Betukumesu Kabesele Dieu merci
Condition:
Haematological Disorders
Paediatrics
Kidney Disease
Haematological Disorders
Paediatrics
Kidney Disease
Intervention:
Hydroxyurea and Losartan
Recru...